
The company's net loss ticked down after March labor cuts.
The company's net loss ticked down after March labor cuts.
The company spent more money on research and cut down on overhead costs.
The psychedelic biopharma shop laid off 30% of its employees.
Can psychedelics really treat the wide range of conditions being considered?
Traditional tactics aren't always the most effective ways to raise capital.
Modern psychiatry and research did not "discover" psychedelics for mental health.
Atai plans to continue working with its compound despite the setback.
Some analysts have called the industry's business model problematic.
Also a peek at their plans for the year ahead.
Even without revenue, psychedelics companies find financing for ongoing research.
Unpack the industry with the daily cannabis newsletter for business leaders.
Unpack the industry with the daily cannabis newsletter for business leaders.